Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacidipine vs Bendrofluazide in Hypertension
NCT02235402Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 1997
- Primary completion
- Mar 2000
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of lacidipine in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Dec 1997; status: completed.
02
Drugs
lacidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02235402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235402.